Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab Extension in Psoriasis
NCT00645892Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Nov 2003
- Primary completion
- Sep 2004
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of adalimumab in plaque psoriasis, sponsored by Abbott Laboratories. Started Nov 2003; status: completed.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00645892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00645892.